• Asserta Global Healthcare Solutions SL

    Asserta Global Healthcare Solutions SL

    Asserta Global Healthcare Solutions SL brings together a team of professionals with years of experience in clinical practice, health management, teaching and research, who are putting their knowledge and expertise at the service of improving processes and results in the healthcare area. While becoming a reference in the Medication management processes, and improving healthcare processes, we have opened a new lines of business related to innovation management, and social impact measurement in international projects. We have consolidated our expertise in Organization and Strategy, Social Innovation in International environments, Real World Data analysis, and international research consultancy. Our team also include experts in planning and strategic management, quality management, technology transfer, financing, information and communication technologies.

  • John Walton Muscular Dystrophy Research Centre – Newcastle University

    John Walton Muscular Dystrophy Research Centre – Newcastle University

    The John Walton Muscular Dystrophy Research Centre is part of the University of Newcastle upon Tyne and works to perform world-class translational research to bring diagnosis, care, and therapy to people with neuromuscular diseases. The European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) is coordinated from the Centre and aims to improve health outcomes in NMD patients across Europe, provide new opportunities for translational research, and reduce the burden of these chronic disabling conditions.

  • Melanoma Patient Network Europe

    Melanoma Patient Network Europe

    MPNE is a loose multidimensional network of European national and regional Melanoma patient forums advocating on behalf of patients and operating across language barriers with shared principles. Our mission is to systematically address problems faced by the European Melanoma community (Adult and Paediatric, Rare and less rare) in a constructive, result-oriented and collaborative manner by providing a platform for advocates to interact and through targeted capacity-building.

  • Òmada Interactiva

    Òmada Interactiva

    Òmada Interactiva is a company with 15 years of experience in consulting, support, design, creation, and development of interactive solutions, developed mostly on open source software. We are a multidisciplinary team focused on offering a solid, innovative and agile approach to web development, communities design, process management and online marketing.
    Health, education, and NGOs are the three major axes we have specialized in.

  • The Synergist

    The Synergist

    The Synergist is a social venture that addresses a growing societal need for collaboration by building partnerships to accelerate societal impact.
    The Synergist acts as an independent, neutral backbone and incubator bringing together the right people, organizations, and institutions together to focus on solving societal issues both personally and with technology tools.

  • Universitat Politècnica de Catalunya

    Universitat Politècnica de Catalunya

    The Universitat Politècnica de Catalunya-BarcelonaTech (Technical University of Catalonia, UPC, http://upc.edu) is a public institution dedicated to higher education and research, specialised in the fields of engineering, architecture and science. It offers higher education in technical fields (69 degrees) and it is composed by 23 schools in 8 different campuses, with a total of 35.000 students and 2.780 researchers. The UPC is ranked 1st in Spain in the Field of Engineering and Technology. UPC participates in Share4Rare from the Bioinformatics and Biomedical Signals Laboratory (B2SLab) at http://b2slab.upc.edu with data analysis technologies.

  • World Duchenne Organization / UPPMD

    World Duchenne Organization / UPPMD

    World Duchenne Organization/UPPMD is a worldwide organization owned and managed by parent project organizations set up by parents of children with Duchenne and Becker Muscular Dystrophy in many different countries all over the world. It is dedicated to finding a cure and viable treatments for DMD, to promoting good standards of care, and to informing parents around the globe.